Synergistic Effects of Amiodarone and Fluconazole on Candida tropicalis Resistant to Fluconazole
Open Access
- 1 April 2013
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (4) , 1691-1700
Abstract
There have recently been significant increases in the prevalence of systemic invasive fungal infections. However, the number of antifungal drugs on the market is limited in comparison to the number of available antibacterial drugs. This fact, coupled with the increased frequency of cross-resistance, makes it necessary to develop new therapeutic strategies. Combination drug therapies have become one of the most widely used and effective strategies to alleviate this problem. Amiodarone (AMD) is classically used for the treatment of atrial fibrillation and is the drug of choice for patients with arrhythmia. Recent studies have shown broad antifungal activity of the drug when administered in combination with fluconazole (FLC). In the present study, we induced resistance to fluconazole in six strains of Candida tropicalis and evaluated potential synergism between fluconazole and amiodarone. The evaluation of drug interaction was determined by calculating the fractional inhibitory concentration and by performing flow cytometry. We conclude that amiodarone, when administered in combination with fluconazole, exhibits activity against strains of C. tropicalis that are resistant to fluconazole, which most likely occurs via changes in the integrity of the yeast cell membrane and the generation of oxidative stress, mitochondrial dysfunction, and DNA damage that could lead to cell death by apoptosis.Keywords
This publication has 53 references indexed in Scilit:
- Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution methodDiagnostic Microbiology and Infectious Disease, 2011
- Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcomeJournal of Microbiology, Immunology and Infection, 2011
- Synthesis and evaluation of quinonoid compounds against tumor cell linesEuropean Journal of Medicinal Chemistry, 2011
- Antifungal Susceptibility of Bloodstream Candida Isolates in Sfax Hospital: TunisiaMycopathologia, 2010
- Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicansAntimicrobial Agents and Chemotherapy, 2010
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance RegistryClinical Infectious Diseases, 2009
- Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance StudyJournal of Clinical Microbiology, 2008
- Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infectionsDiagnostic Microbiology and Infectious Disease, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in miceAntimicrobial Agents and Chemotherapy, 1995